Copyright
©The Author(s) 2017.
World J Gastrointest Endosc. Apr 16, 2017; 9(4): 189-195
Published online Apr 16, 2017. doi: 10.4253/wjge.v9.i4.189
Published online Apr 16, 2017. doi: 10.4253/wjge.v9.i4.189
Variables | No. of patients | Median of patients (range) | Univariate analysis P value |
Age (yr) (n = 121) | 76 (18-91) | 0.874 | |
Gender (n = 121) | 0.818 | ||
Male/female | 64/57 | ||
BMI (kg/m2) (n = 121) | 21.2 (14.0-35.2) | 0.379 | |
Smoking status (n = 121) | 0.201 | ||
Non-smoker/Ex- or current smoker | 90/31 | ||
Drinking status (n = 121) | 0.302 | ||
Absent/present | 79/42 | ||
Past history (n = 121) | 0.967 | ||
Absent/present | 35/86 | ||
Malignant disease (n = 121) | 0.550 | ||
Absent/present | 94/27 | ||
History of pancreatitis (n = 121) | 0.606 | ||
Absent/present | 119/7 | ||
SOD (n = 121) | 0.644 | ||
Absent/present | 114/7 | ||
Diverticulum nearby vater papilla (n = 121) | 0.325 | ||
Absent/present | 81/40 | ||
CBD diameter of patient with CBD stones (n = 41) | 0.796 | ||
≥ 10 mm/< 10 mm | 23/18 |
- Citation: Matsubara H, Urano F, Kinoshita Y, Okamura S, Kawashima H, Goto H, Hirooka Y. Analysis of the risk factors for severity in post endoscopic retrograde cholangiopancreatography pancreatitis: The indication of prophylactic treatments. World J Gastrointest Endosc 2017; 9(4): 189-195
- URL: https://www.wjgnet.com/1948-5190/full/v9/i4/189.htm
- DOI: https://dx.doi.org/10.4253/wjge.v9.i4.189